Psychiatry · Indianapolis, IN
NPI
1114979051
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
9106 N Meridian St, Suite 100
Indianapolis, IN, 46260
Phone (317) 575-9111
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$35K
172 prescriptions
Company payments, 2025
$1,014
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jason H Rowland prescribed most often to Medicare patients was Vilazodone Hcl, with 33 prescriptions and refills. In total Jason H Rowland wrote 172 Medicare prescriptions that cost $35K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Vilazodone Hcl Generic | 33 | 45 | Under 11 | $5,922 |
| Bupropion Xl Bupropion Hcl | 19 | 39 | Under 11 | $987 |
| Guanfacine Hcl Er Guanfacine Hcl | 15 | 35 | Under 11 | $5,780 |
| Lamotrigine Generic | 14 | 42 | Under 11 | $207 |
| Buspirone Hcl Generic | 13 | 39 | Under 11 | $366 |
Brand drugs: 16 claims; generic drugs: 156 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jason H Rowland $1,014 ($1,014 in general payments such as food, travel and fees) from 14 companies. The largest payer was Axsome Therapeutics, Inc. with $188.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 9 | $188 |
| Vanda Pharmaceuticals Inc. VNDA | 7 | $178 |
| Supernus Pharmaceuticals, Inc. SUPN | 5 | $116 |
| Noven Therapeutics, LLC | 5 | $107 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $98.57 |
| Corium, LLC | 3 | $79.32 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $46.9 |
| Neos Therapeutics, LP | 2 | $46.67 |
| Abbvie Inc. ABBV | 2 | $41.77 |
| Tris Pharma Inc | 2 | $38.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.